Pelthos Therapeutics (PTHS) Debt Ratio (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Debt Ratio of 0.16 for Q2 2025, up 216.41% year-over-year from 0.05 in Q2 2024, and up 10.73% quarter-over-quarter from 0.14 in Q1 2025.
Pelthos Therapeutics (PTHS) Debt Ratio (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.16 for Q2 2025.
- In Q2 2025, Debt Ratio rose 216.41% year-over-year to 0.16; the TTM figure through Jun 2025 stood at 0.16 (up 216.41% YoY), while the FY2024 annual figure was 0.19, down 97.52% from the prior year.
- Debt Ratio for Q2 2025 stood at 0.16, up from 0.14 in the prior quarter.
- The five-year high for Debt Ratio was 7.78 in Q4 2023, with the low at 0.05 in Q2 2024.
- The 4-year median for Debt Ratio is 0.16 (2025), against an average of 1.47.
- The sharpest annual moves came in 2023 and 2024: Debt Ratio soared 308.94% in 2023, then tumbled 97.52% in 2024.
- Pelthos Therapeutics' Debt Ratio stood at 1.9 in 2022, then soared by 308.94% to 7.78 in 2023, then sank by 97.52% to 0.19 in 2024, then slipped by 16.9% to 0.16 in 2025.
- Business Quant data shows PTHS's Debt Ratio at 0.16 in Q2 2025, 0.14 in Q1 2025, and 0.19 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 0.47 |
| 10 | Pelthos Therapeutics | 93.05 Mn | 68.49 Mn | 21.23 Mn | 0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.19 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | 0.19 |
| Sep 30, 2024 | 0.06 |
| Jun 30, 2024 | 0.05 |
| Dec 31, 2023 | 7.78 |
| Dec 31, 2022 | 1.90 |